Elastagen Pty. Limited
Eveleigh, AU· latest recorded location
ELASTAGEN PTY. LIMITED is named on 2 US grants and 9 published applications in this corpus. Its most frequent classification is C07K (Peptides).
- Granted patents
- 2
- Published applications
- 9
- Inventors
- 6
- Granted in 2026 so far
- 0
- Most recent grant
- 27 Jun 2017
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 2 |
| 2017 | 2 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 2 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year.
Technology areas
Share of 11 documents
- C07KPeptides11
- A61LMethods or apparatus for sterilising materials or objects in general10
- A61KMedicines and medical preparations7
- A61PTherapeutic uses of medicines6
- A61FFilters implantable into blood vessels3
- A61QSpecific use of cosmetics or similar toiletry preparations3
- C08BPolysaccharides3
- C08HDerivatives of natural macromolecular compounds3
- C08LCompositions of macromolecular compounds3
- C12NMicroorganisms or enzymes2
Recent patents
- Elastic hydrogel27 Jun 2017US 9,688,741 B2
- Preparation and/or formulation of proteins cross-linked with polysaccharides4 Apr 2017US 9,611,312 B2
- Biosynthetic devices13 Jun 2024US 2024/0189477 A1
- Regeneration of damaged tissue31 Mar 2022US 2022/0098281 A1
- Biosynthetic devices12 Sep 2019US 2019/0275204 A1
- Regeneration of damaged tissue28 Feb 2019US 2019/0062405 A1
- Preparation and/or Formulation of Proteins Cross-Linked with Polysaccharides20 Jul 2017US 2017/0203001 A1
Most cited
By later US patents